Informations:
Erreur:
Mots-clés
Treatment Form ×
- Clinical Trial (682)
- Breast Neoplasms (132)
- Leukemia (44)
- Lung Neoplasms (43)
- Colorectal Neoplasms (41)
- Prostatic Neoplasms (36)
- Brain Neoplasms (30)
- AML (29)
- Leukemia, Myeloid, Acute (26)
- Central Nervous System Neoplasms (25)
- Multiple Myeloma (25)
- Testosterone (18)
- Drugs, Investigational (18)
- Endometrial Neoplasms (18)
- Hypogonadism (18)
- Sarcoma, Kaposi (17)
- Uterine Cervical Neoplasms (17)
- Head and Neck Neoplasms (17)
- Pancreatic Neoplasms (17)
- Consent Forms (13)
- Fallopian Tube Neoplasms (13)
- Lymphoma, Non-Hodgkin (13)
- Rhabdomyosarcoma (11)
- Urinary Bladder Neoplasms (10)
- Melanoma (10)
- Drug trial (9)
- Leukemia, Myelomonocytic, Juvenile (8)
- On-Study Form (8)
- Myelodysplastic Syndromes (8)
- Neoplasms, Germ Cell and Embryonal (8)
- Neoplasms, Plasma Cell (7)
- Anemia, Aplastic (7)
- Neoplasms (7)
- Clinical Trial, Phase I (6)
- Vital Signs (6)
- Lymphoma (6)
- Sarcoma, Ewing (5)
- Cross-Over Studies (5)
- Diabetes Mellitus, Type 2 (5)
- Double-Blind Method (5)
- Esophageal Neoplasms (5)
- Graft vs Host Disease (5)
- Kidney Neoplasms (5)
- Placebos (4)
- Burkitt Lymphoma (4)
- Adenocarcinoma (4)
- Parkinsons Disease (4)
- Gynecology (4)
- Migraine Disorders (4)
- Pregnancy (3)
- Transplantation (3)
- Randomized Controlled Trial (3)
- Lymphoma, AIDS-Related (3)
- Clinical Trial, Phase III (3)
- Hematopoietic Stem Cell Transplantation (3)
- Dyskinesias (3)
- Pulmonary Disease, Chronic Obstructive (3)
- Adverse event (3)
- Concomitant Medication (3)
- End of Study (3)
- Esophagus (3)
- Hypertension (3)
- Infection (3)
- Liver Neoplasms (3)
- Anus Neoplasms (3)
- Radiation (2)
- Asthma (2)
- Sarcoma (2)
- Signs and Symptoms (2)
- Soft Tissue Neoplasms (2)
- Gynecologic Surgical Procedures (2)
- Leukemia, Lymphocytic, Chronic, B-Cell (2)
- Chemotherapy, Adjuvant (2)
- Bone Neoplasms (2)
- Measles-Mumps-Rubella Vaccine (2)
- Gastrointestinal Stromal Tumors (2)
- Atherosclerosis (2)
- Healthy Volunteers (2)
- Bone metastasis (2)
- Chest X- ray (2)
- Coronary Disease (2)
- Dental Caries (2)
- Gastrointestinal Neoplasms (2)
- Laboratories (2)
- Medical Oncology (2)
- Neoplasm Metastasis (2)
- Neurology (2)
- Ovarian Neoplasms (2)
- Peritoneal Neoplasms (1)
- Pharmacokinetics (1)
- Physical Examination (1)
- Pneumonia (1)
- Radiotherapy (1)
- Research Personnel (1)
- Restless Legs Syndrome (1)
- Rhinitis, Allergic, Perennial (1)
- Safety (1)
- Stomach Neoplasms (1)
- General Surgery (1)
Table des matières
Modèles de données sélectionnés
Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.
682 Résultats de recherche.
Groupes Item: Header, Endocrine therapy, Footer Module
Groupe Item: Infection Episode
Groupes Item: MODULE 1, Summary of Systemic Treatment, Summary of Systemic Treatment, Protocol Specific Adverse Events Evaluation, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS, Footer
Groupe Item: Infection Episode
Groupes Item: RTOG clinical trial administrative data, Assessment of Chemotherapy, REPORT ALL CONTINUING OR NEW ADVERSE EVENTS
Groupes Item: Header - Interventions Form, Interventions, Comments
Groupe Item: Prior Radiation Supplement
Groupes Item: Header - Interventions Form, Interventions, Comments
Groupes Item: Header, Primary Surgery, REASON FOR SURGERY, CNS PERI-OPERATIVE COMPLICATIONS, POST-OP STEROIDS USED, Comments, CCRR MODULE
Groupes Item: Patient Information, Cause of Death, Autopsy, Adverse Event Status, Therapy for Lower Urinary Tract Symptoms/Prostate Cancer since the last report, Other Malignancies or Marrow Dysplasia, Comments, Supporting Documentation, Form Completion
Groupes Item: Allgemeine Angaben, Nichtoperative Therapie - Analgetika, Nichtoperative Therapie - Physikalische Therapie, Nichtoperative Therapie - Medikamentöse Therapie, Operative Therapie - Gelenkerhaltende Therapie, Operative Therapie - Gelenkersatz
Groupes Item: Header, Patient demographics, SPECIMEN DETAILS, GROSS FINDINGS, HISTOLOGIC FINDINGS, MARGINS, DCIS, LYMPH NODES, DISEASE STAGING, COMMENTS